Nachman Norwood & Parrott’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $905K | Buy |
15,108
+92
| +0.6% | +$5.51K | 0.09% | 138 |
|
|
2021
Q1 | $746K | Buy |
15,016
+868
| +6% | +$43.1K | 0.08% | 149 |
|
|
2020
Q4 | $707K | Hold |
14,148
| – | – | 0.08% | 144 |
|
|
2020
Q3 | $775K | Sell |
14,148
-48
| -0.3% | -$2.63K | 0.1% | 124 |
|
|
2020
Q2 | $751K | Sell |
14,196
-24
| -0.2% | -$1.27K | 0.12% | 122 |
|
|
2020
Q1 | $635K | Buy |
14,220
+52
| +0.4% | +$2.32K | 0.13% | 119 |
|
|
2019
Q4 | $706K | Hold |
14,168
| – | – | 0.12% | 135 |
|
|
2019
Q3 | $631K | Hold |
14,168
| – | – | 0.11% | 137 |
|
|
2019
Q2 | $585K | Sell |
14,168
-86
| -0.6% | -$3.55K | 0.11% | 139 |
|
|
2019
Q1 | $576K | Hold |
14,254
| – | – | 0.11% | 135 |
|
|
2018
Q4 | $541K | Buy |
+14,254
| New | +$541K | 0.11% | 131 |
|